Contact us

8 Results:

Sort By:

Late-Onset Sepsis Reduced in Premature Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers as Part of an Exclusive Human Milk Diet

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis

Why Human Milk Plays an Essential Role in Preemie Development

Type: Prolacta in the News

Topic(s): Late-Onset Sepsis Necrotizing Entercolitis (NEC)

Understanding neonatal sepsis

Type: Blog

Topic(s): Late-Onset Sepsis Parents

Economic Benefits and Costs of Human Milk Feedings | Latch

Type: Blog

Topic(s): Bronchopulmonary Dysplasia (BPD) Late-Onset Sepsis Necrotizing Entercolitis (NEC) Neurodevelopmental Outcomes

Prolacta Bioscience Supports Prematurity Awareness Month with New Educational Resources for Parents of Preemies

Type: Press Releases

Topic(s): Late-Onset Sepsis Necrotizing Entercolitis (NEC)

Interview: The Benefits of Early Enteral Feeding

Type: Prolacta in the News

Topic(s): Feeding Protocols Late-Onset Sepsis Necrotizing Entercolitis (NEC)

Prolacta Bioscience Brings Together International Experts for Human-Milk Symposium

Type: Press Releases

Topic(s): Conferences and Events Late-Onset Sepsis Necrotizing Entercolitis (NEC)

New Scientific Report Supports the Use of Prolacta’s Neonatal Nutritional Products in Extremely Premature Infants

Type: Press Releases

Topic(s): Clinical Studies Late-Onset Sepsis Necrotizing Entercolitis (NEC)

Not finding the reference you’re looking for?

Email us at info@prolacta.com